Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation

Molecules

Volumn 21, Issue 4, 2016, Pages

  Tsai, Tzung Hsun ^a   Huang, Wen Cheng ^b,c   Ying, How Ting ^c   Kuo, Yueh Hsiung ^d,e   Shen, Chien Chang ^f   Lin, Yin Ku ^a   Tsai, Po Jung ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI TZU CHI HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Anti inflammation; Cucurbitane triterpenoid; Porphyromonas gingivalis; Wild bitter melon

Indexed keywords

CUCURBITANE; GLYCOSIDE; PLANT EXTRACT; TRITERPENE;

ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; HUMAN; INFLAMMATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOMORDICA CHARANTIA; MOUSE; PATHOGENICITY; PLANT LEAF; PORPHYROMONAS GINGIVALIS;

ANIMALS; CELL LINE; GLYCOSIDES; HUMANS; INFLAMMATION; MICE; MOMORDICA CHARANTIA; PLANT EXTRACTS; PLANT LEAVES; PORPHYROMONAS GINGIVALIS; TRITERPENES;

EID: 84966340186     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21040454     Document Type: Article

References (49)

1. Hajishengallis, G. Periodontitis: From microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 2015, 15, 30-44. [CrossRef] [PubMed]
2. Hajishengallis, G.; Sojar, H.; Genco, R.J.; DeNardin, E. Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors. Immunol. Investig. 2004, 33, 157-172. [CrossRef]
3. Hiramine, H.; Watanabe, K.; Hamada, N.; Umemoto, T. Porphyromonas gingivalis 67-kDa fimbriae induced cytokine production and osteoclast differentiation utilizing TLR2. FEMS Microbiol. Lett. 2003, 229, 49-55. [CrossRef]
4. Imatani, T.; Kato, T.; Okuda, K. Production of inflammatory cytokines by human gingival fibroblasts stimulated by cell-surface preparations of Porphyromonas gingivalis. Oral Microbiol. Immunol. 2001, 16, 65-72. [CrossRef] [PubMed]
5. Kato, Y.; Hagiwara, M.; Ishihara, Y.; Isoda, R.; Sugiura, S.; Komatsu, T.; Ishida, N.; Noguchi, T.; Matsushita, K. TNF-α augmented Porphyromonas gingivalis invasion in human gingival epithelial cells through Rab5 and ICAM-1. BMC Microbiol. 2014, 14, 229. [CrossRef] [PubMed]
6. Mysak, J.; Podzimek, S.; Sommerova, P.; Lyuya-Mi, Y.; Bartova, J.; Janatova, T.; Prochazkova, J.; Duskova, J. Porphyromonas gingivalis: Major periodontopathic pathogen overview. J. Immunol. Res. 2014, 2014. [CrossRef] [PubMed]
7. Birkedal-Hansen, H. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal. Res. 1993, 28, 500-510. [CrossRef] [PubMed]
8. Bickel, M. The role of interleukin-8 in inflammation and mechanisms of regulation. J. Periodontol. 1993, 64 (Suppl. S5), 456-460. [PubMed]
9. Okada, H.; Murakami, S. Cytokine expression in periodontal health and disease. Crit. Rev. Oral Biol. Med. 1998, 9, 248-266. [CrossRef] [PubMed]
10. Azuma, M.M.; Samuel, R.O.; Gomes-Filho, J.E.; Dezan-Junior, E.; Cintra, L.T.A. The role of IL-6 on apical periodontitis: A systematic review. Int. Endod. J. 2014, 47, 615-621. [CrossRef] [PubMed]
11. Schwartz, Z.; Goultschin, J.; Dean, D.D.; Boyan, B.D. Mechanisms of alveolar bone destruction in periodontitis. Periodontol. 2000 1997, 14, 158-172. [CrossRef] [PubMed]
12. Rossomando, E.F.; Kennedy, J.E.; Hadjimichael, J. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch. Oral Biol. 1990, 35, 431-434. [CrossRef]
13. Kato, H.; Taguchi, Y.; Tominaga, K.; Umeda, M.; Tanaka, A. Porphyromonas gingivalis LPS inhibits osteoblastic differentiation and promotes pro-inflammatory cytokine production in human periodontal ligament stem cells. Arch. Oral Biol. 2014, 59, 167-175. [CrossRef] [PubMed]
14. Noh, M.K.; Jung, M.; Kim, S.H.; Lee, S.; Park, K.H.; Kim, D.H.; Kim, H.H.; Park, Y.G. Assessment of IL-6, IL-8 and TNF-α levels in the gingival tissue of patients with periodontitis. Exp. Ther. Med. 2013, 6, 847-851. [PubMed]
15. Andrukhov, O.; Ulm, C.; Reischl, H.; Nguyen, P.Q.; Matejka, M.; Rausch-Fan, X. Serum cytokine levels in periodontitis patients in relation to the bacterial load. J. Periodontaol. 2011, 82, 885-892. [CrossRef] [PubMed]
16. Saengsai, J.; Kongtunjanphuk, S.; Yoswatthana, N.; Kummalue, T.; Jiratchariyakul, W. Antibacterial and antiproliferative activities of plumericin, an iridoid Isolated from Momordica charantia vine. Evid. Based Complement. Altern. Med. 2015, 2015. [CrossRef] [PubMed]
17. Kubola, J.; Siriamornpun, S. Phenolic contents and antioxidant activities of bitter gourd (Momordica charantia L.) leaf, stem and fruit fraction extracts in vitro. Food Chem. 2008, 110, 881-890. [PubMed]
18. Nagarani, G.; Abirami, A.; Siddhuraju, P. Food prospects and nutraceutical attributes of Momordica species: A potential tropical bioresources-A review. Food Sci. Hum. Wellness 2014, 3, 36-46. [CrossRef]
19. Tsai, T.H.; Huang, C.J.; Wu, W.H.; Huang, W.C.; Chyuan, J.H.; Tsai, P.J. Antioxidant, cell-protective, and anti-melanogenic activities of leaf extracts from wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) cultivars. Bot. Stud. 2014, 55, 78-88. [CrossRef]
20. Huang, W.C.; Tsai, T.H.; Huang, C.J.; Li, Y.Y.; Chyuan, J.H.; Chuang, L.T.; Tsai, P.J. Inhibitory effects of wild bitter melon leaf extract on Propionibacterium acnes-induced skin inflammation in mouse and cytokine production in vitro. Food Funct. 2015, 6, 2550-2560. [CrossRef] [PubMed]
21. Huang, W.C. Bioassay-Guided Isolation and Identification of Anti-Inflammatory Compounds from Wild Bitter Melon Leaf against Propionibacterium acnes. Ph.D. Thesis, National Taiwan Normal University, Taipei, Taiwan, 2016.
22. Petrovic, M.S.; Kesic, L.G.; Kitic, D.V.; Mila?in, J.M.; Obradovic, R.R.; Bojovic, M.D.; Simonovic, A.A. Periodontal disease and phytotherapy. Org. Hyg. Health 2015, 3, 172-175.
23. Jagan Rao, N.; Subash, K.R.; Sandeep Kumar, K. Role of phytotherapy in gingivitis: A review. Int. J. Pharmacol. 2012, 8, 1-5. [CrossRef]
24. Lii, C.K.; Chen, H.W.; Yun, W.T.; Liu, K. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviate ser.) fruit extracts on inflammatory responses in RAW 264.7 macrophages. J. Ethnopharmacol. 2009, 122, 227-233. [CrossRef] [PubMed]
25. Hsu, C.; Tsai, T.H.; Li, Y.Y.; Wu, W.H.; Huang, C.J.; Tsai, P.J. Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation. Food Chem. 2012, 135, 976-984. [CrossRef] [PubMed]
26. Ciou, S.Y.; Hsu, C.C.; Kuo, Y.H.; Chao, C.Y. Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis. Biomedicine 2014, 4, 7-13. [CrossRef] [PubMed]
27. Kimura, S.; Ohara-Nemoto, Y.; Shimoyama, Y.; Ishikawa, T.; Sasaki, M. Pathogenic factors of P. gingivalis and the host defense mechanisms. In Pathogenesis and Treatment of Periodontitis; Buduneli, N., Ed.; InTech: Rijeka, Croatia, 2012.
28. Lim, T.K. Momordica charantia. In Edible Medicinal and Non-Medicinal Plants; Lim, T.K., Ed.; Springer: New York, NY, USA, 2012; Volume 2, pp. 331-368.
29. Hsu, C.; Hsieh, C.L.; Kuo, Y.H.; Huang, C.J. Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia. J. Agric. Food Chem. 2011, 59, 4553-4561. [CrossRef] [PubMed]
30. Chen, C.R.; Liao, Y.W.; Wang, L.; Kuo, Y.H.; Liu, H.J.; Shih, W.L.; Cheng, H.L.; Chang, C.I. Cucurbitane triterpenoids from Momordica charantia and their cytoprotective activity in tert-butyl hydroperoxide-induced hepatotoxicity of HepG2 cells. Chem. Pharm. Bull. 2010, 58, 1639-1642. [CrossRef] [PubMed]
31. Weng, J.R.; Bai, L.Y.; Chiu, C.F.; Hu, J.L.; Chiu, S.J.; Wu, C.Y. Cucurbitane triterpenoid from Momordica charantia induces apoptosis and autophagy in breast cancer cells, in part, through peroxisome proliferator-activated receptor ã activation. Evid. Based Complement. Altern. Med. 2013, 2013, 935675. [CrossRef] [PubMed]
32. Cheng, H.L.; Huang, H.K.; Chang, C.I.; Tsai, C.P.; Chou, C.H. A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase. J. Agric. Food Chem. 2008, 56, 6835-6843. [CrossRef] [PubMed]
33. Zhang, J.; Huang, Y.; Kikuchi, T.; Tokuda, H.; Suzuki, N.; Inafuku, K.; Miura, M.; Motohashi, S.; Suzuki, T.; Akihisa, T. Cucurbitane triterpenoids from the leaves of Momordica charantia, and their cancer chemopreventive effects and cytotoxicities. Chem. Biodivers. 2012, 9, 428-440. [CrossRef] [PubMed]
34. Harinantenaina, L.; Tanaka, M.; Takaoka, S.; Oda, M.; Mogami, O.; Uchida, M.; Asakawa, Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem. Pharm. Bull. 2006, 54, 1017-1021. [CrossRef] [PubMed]
35. Zhao, G.T.; Liu, J.Q.; Deng, Y.Y.; Li, H.Z.; Chen, J.C.; Zhang, Z.R.; Zhou, L.; Qiu, M.H. Cucurbitane-type triterpenoids from the stems and leaves of Momordica charantia. Fitoterapia 2014, 95, 75-82. [CrossRef] [PubMed]
36. Xiang, Z.B.; Tang, C.H.; Chen, G.; Shi, Y.S. Study on colorimetric determination of oleanolic acid in Chinese quince. Nat. Prod. Res. Dev. 2001, 13, 23-26.
37. Zhou, Q.; Amar, S. Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components. J. Immunol. 2007, 179, 7777-7790. [CrossRef] [PubMed]
38. Liu, J.; Wang, Y.; Ouyang, X. Beyond toll-like receptors: Porphyromonas gingivalis induces IL-6, IL-8, and VCAM-1 expression through NOD-mediated NF-êB and ERK signaling pathways in periodontal fibroblasts. Inflammation 2014, 37, 522-533. [CrossRef] [PubMed]
39. Newton, K.; Dixit, V.M. Signaling in Innate Immunity and Inflammation. Cold Spring Harb. Perspect. Biol. 2012, 4, a006049. [CrossRef] [PubMed]
40. Hienz, S.A.; Paliwal, S.; Ivanoki, S. Mechanisms of bone resorption in periodontitis. J. Immunol. Res. 2015, 2015, 615486. [CrossRef] [PubMed]
41. Cochran, D.L. Inflammation and bone loss in periodontal disease. J. Periodontol. 2008, 79, 1569-1576. [CrossRef] [PubMed]
42. Mesa, F.; Aguilar, M.; Galindo-Moreno, P.; Bravo, M.; O'Valle, F. Cyclooxygenase-2 expression in gingival biopsies from periodontal patients is correlated with connective tissue loss. J. Periodontol. 2012, 83, 1538-1545. [CrossRef] [PubMed]
43. Younis, M.N.; Machtei, E.E.; Oetlinger-Barak, O.; Peled, M. The significance of gingival crevicular fluid and IL-1β, TNF-α and PGE2 in periodontal disease: A literature review. Oral Biosci. Med. 2004, 1, 249-257.
44. Fatope, M.O.; Takeda, Y.; Yamashita, H.; Okabe, H.; Yamauchi, T. New cucurbitane triterpenoids from Momordica charantia. J. Nat. Prod. 1990, 53, 1491-1497. [CrossRef]
45. Mulholland, D.A.; Sewram, V.; Osborne, R.; Pegel, K.H.; Connolly, J.D. Cucurbitane triterpenoids from the leaves of Momordica foetida. Phytochemistry 1997, 45, 391-395. [CrossRef]
46. Baqui, A.A.M.A.; Meiller, T.F.; Falkler, W.A. Enhanced interleukin-8 production in THP-1 human monocytic cells by lipopolysaccharide from oral microorganisms and granulocyte-macrophage colony-stimulating factor. Oral Microbiol. Immunol. 1999, 14, 275-280. [CrossRef] [PubMed]
47. Zhang, D.; Chen, L.; Li, S.; Gu, Z.; Yan, J. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1β, TNF-α and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun. 2008, 14, 99-107. [CrossRef] [PubMed]
48. Gutiérrez-Venegas, G.; Contreras-Sa?nchez, A. Luteolin and fisetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in human gingival fibroblasts. Mol. Biol. Rep. 2013, 40, 477-485. [CrossRef] [PubMed]
49. De Molon, R.S.; de Avila, E.D.; Boas Nogueira, A.V.; Chaves de Souza, J.A.; Avila-Campos, M.J.; de Andrade, C.R.; Cirelli, J.A. Evaluation of the host response in various models of induced periodontal disease in mice. J. Periodontol. 2014, 85, 465-477. [CrossRef] [PubMed]